What is he best known for?
The fields of study he is best known for:
Anthony H. Futerman spends much of his time researching Biochemistry, Ceramide, Sphingolipid, Cell biology and Sphingomyelin.
Golgi apparatus, Phosphatidylinositol, Enzyme, Membrane and Inositol are subfields of Biochemistry in which his conducts study.
His Ceramide research is multidisciplinary, relying on both Signal transduction, Lipid signaling, Metabolic pathway and Nerve growth factor.
His Sphingolipid research includes elements of Sphingosine, Fumonisin B1, Ceramide synthase 2, Ceramide synthase and Fatty acid.
His Ceramide synthase 2 research integrates issues from Acyl-CoA and Endocrinology.
Anthony H. Futerman interconnects Hippocampal formation, Sphingosine-1-phosphate and Programmed cell death in the investigation of issues within Cell biology.
His most cited work include:
- The cell biology of lysosomal storage disorders. (622 citations)
- The complex life of simple sphingolipids (517 citations)
- When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. (360 citations)
What are the main themes of his work throughout his whole career to date?
Anthony H. Futerman mostly deals with Biochemistry, Ceramide, Sphingolipid, Cell biology and Sphingomyelin.
His work is dedicated to discovering how Biochemistry, Stereochemistry are connected with Active site and Hydrolase and other disciplines.
Anthony H. Futerman combines subjects such as Sphingosine, Lipid signaling and Metabolic pathway with his study of Ceramide.
His Sphingolipid study incorporates themes from Endocrinology, Fumonisin B1, Ceramide synthase 2, Ceramide synthase and Internal medicine.
His research investigates the connection between Cell biology and topics such as Programmed cell death that intersect with issues in Glucocerebrosidase.
His Endoplasmic reticulum study combines topics from a wide range of disciplines, such as Microsome and Intracellular.
He most often published in these fields:
- Biochemistry (39.86%)
- Ceramide (36.77%)
- Sphingolipid (35.40%)
What were the highlights of his more recent work (between 2013-2021)?
- Sphingolipid (35.40%)
- Ceramide (36.77%)
- Cell biology (34.36%)
In recent papers he was focusing on the following fields of study:
Anthony H. Futerman focuses on Sphingolipid, Ceramide, Cell biology, Biochemistry and Immunology.
His Sphingolipid research is multidisciplinary, relying on both Endocrinology, Sphingomyelin, Internal medicine and Ceramide synthase, Ceramide synthase 2.
In Ceramide, Anthony H. Futerman works on issues like Sphingosine, which are connected to Lung.
In his research on the topic of Cell biology, Cell membrane is strongly related with Membrane protein.
As a part of the same scientific family, he mostly works in the field of Immunology, focusing on Disease and, on occasion, Phenotype.
His studies in Cell integrate themes in fields like Membrane fluidity and Biological membrane.
Between 2013 and 2021, his most popular works were:
- CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance (257 citations)
- A Dynamic Interface between Vacuoles and Mitochondria in Yeast (245 citations)
- Ceramide synthases as potential targets for therapeutic intervention in human diseases (132 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Sphingolipid, Ceramide, Cell biology, Biochemistry and Immunology.
His work carried out in the field of Sphingolipid brings together such families of science as Endocrinology, Internal medicine, Ceramide synthase 2, Gene and Sphingomyelin phosphodiesterase.
Ceramide is frequently linked to Sphingosine in his study.
His Cell biology research includes elements of ERMES, Programmed cell death, Sphingomyelin and Membrane protein.
Anthony H. Futerman has researched Programmed cell death in several fields, including Autophagy, Neurodegeneration and Glucocerebrosidase.
His research integrates issues of Disease and Gaucher's disease in his study of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
